Estrogen-Progestogen Replacement in Climacteric Women, Particularly as Regards a New Type of Continuous Regimen

References

• Borglin N E., Staland B. Oral treatment of menopausal symptoms with natural oestrogens. Acta Obstet Gynecol Scand 1975, Suppl. 43: 1–11
   Google Scholar
• Bullock J L., Massey M F., Gambrell R D. Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol 1975; 46: 165–8
   PubMed Web of Science ®Google Scholar
• Callantine M R., Martin P L., Bolding O T., Warner P O., Greaney M O. Micronized 17-β-estradiol for oral estrogen therapy in menopausal women. Obstet Gynecol 1975; 46: 37–41
   PubMed Web of Science ®Google Scholar
• Campbell S, Minardi J, McQueen J, Whitehead M I. The modifying effect of progestogen on the response of the postmenopausal endometrium to exogenous estrogens. Postgrad Med 1978; 54(Suppl 2)59–64
   Google Scholar
• Dada O A., Laumas V, Landgren B M., Cekan S Z., Diczfalusy E. Effect of graded oral doses of estradiol on circulating hormonal levels. Acta Endocrinol (Copenh) 1978; 88: 754–67
   Google Scholar
• Dennefors B L., Jansson P O., Knutson F, et al. Steroid production and responsiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries. Am J Obstet Gynecol 1980; 136: 997–1002
   PubMed Web of Science ®Google Scholar
• Gambrell R D., Jr. Postmenopausal bleeding. Clinics in Obstetrics and Gynaecology, R G. Greenblatt, J WW Studd. W. B. Saunders, London 1977; vol 4: 129–143
   Google Scholar
• Gambrell R D., Jr, Massey F M., Castaneda T A., Ugenas A J., Ricci C A., Wright J M. Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol 1980; 55: 732–8
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli W P., Hjortland M C., et al. Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Intern Med 1977; 87: 393–7
   PubMed Web of Science ®Google Scholar
• Greenblatt R B., Colle M L., Mahesh V B. Ovarian and adrenal steroid production in the postmenopausal women. Obstet Gynecol 1976; 47: 383–7
   PubMed Web of Science ®Google Scholar
• Helgason S, Carlström K, Damber M G., et al. Effects of various oestrogens on circulating androgens and Cortisol during replacement therapy in post-menopausal women. Maturitas 1981; 3: 301–8
   PubMed Web of Science ®Google Scholar
• Lind T, Cameron E C., Hunter W M., Leon C, Moran P F., Oxley A, Gerrard J, Lind U CG. A prospective controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol 1979; 86(Suppl. 3)1–29
   PubMedGoogle Scholar
• Mattsson L Å, Cullberg G, Tangkeo P, Zador G, Samsioe G. Administration of dehydroepiandrosterone enanthate to oophorectomized women—effects on sex hormones and lipid metabolism. Maturitas 1980; 2: 301–9
   Google Scholar
• Mattsson L Å, Abrahamsson L, Cullberg G, Samsioe G. Effects of a continuous estrogen - progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins. Arch Gynecol 1983; 233: 101–7
   Google Scholar
• Meade T W., Greenberg G, Thompson S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50-and 30-μg preparations. Br Med J 1980; 280: 1157–61
   PubMed Web of Science ®Google Scholar
• Miller G J. Clinical implications of hormonal changes in lipoprotein metabolism, with special reference to the progestins. Progesterone and Progestins, C W. Bardin, E Milgrom, P Mauvais-Jarvis. Raven Press, New York 1983; 433–46
   Google Scholar
• Paterson M EL, Wade-Evans I, Sturdee D W., Thorn M H., Studd J WW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980; 280: 822–4
   PubMed Web of Science ®Google Scholar
• Ryan K J., Engel L L. The interconversion of estrone and estradiol by human tissue slices. Endocrinology 1953; 52: 287–91
   PubMed Web of Science ®Google Scholar
• Sexton L, Lenton E A., Anderton K J., Brooke L M., Cooke I D. The effects of Premarin and norgestrel on plasma FSH, LH and androstenedione in postmenopausal women. Postgrad Med J 1978; 54(Suppl 2)42–6
   Google Scholar
• Siddle N C., Townsend P T., Young O, Minardi J, King R IB, Whitehead M I. Dose-dependent effects of synthetic progestins on the biochemistry of the estrogeniz-ed postmenopausal endometrium. Acta Obstet Gynecol Scand 1982, Suppl. 106: 17–22
   Google Scholar
• Silfverstolpe G, Gustafson A, Samsioe G, et al. Lipid metabolic studies in oophorectomized women. Effects of three different progestogens. Acta Obstet Gynecol Scand 1979, Suppl. 88: 89–95
   Google Scholar
• Strecker J R., Lauritzen C, Goessens L. Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause. Maturitas 1979; 1: 183–90
   Google Scholar
• Sturdee D W., Wade-Evans T, Paterson M EL, Thorn M, Studd J WW. Relations between bleeding pattern, endometrial histology, and oestrogen treatment in menopausal women. Br Med J 1978; 1: 1575–77
   PubMed Web of Science ®Google Scholar
• Tikkanen M J., Nikkila E A., Kuusi T, et al. High density lipoprotein-2 and hepatic lipase: Reciprocal changes produced by estrogen and norgestrel. J Clin Endocrinol Metab 1982; 54: 1113–7
   PubMed Web of Science ®Google Scholar
• Wallentin L, Larsson-Cohn U. Metabolic and hormonal effects of postmenopausal oestrogen replacement. II. Plasma lipids. Acta Endocrinol (Copenh) 1977; 86: 597–607
   PubMedGoogle Scholar
• Witztum J, Schonfeld G. High density lipoprotein. Diabetes 1979; 28: 326–36
   PubMed Web of Science ®Google Scholar
• Yen S SC, Martin P L., Burnier A M., Czekala N M., Greaney M O., Jr, Callantine M R. Circulating estradiol, estrone and gonadotrophin leves following the administration of orally active 17 -β-estradiol in postmenopausal women. J Clin Endocrinol 1975; 40: 518–21
   PubMed Web of Science ®Google Scholar